The Chemours Company (CC) is a publicly traded Basic Materials sector company. As of July 9, 2026, CC trades at $17.60 with a market cap of $2.76B and a P/E ratio of 30.17. CC moved -5.39% today. Year to date, CC is +47.50%; over the trailing twelve months it is +26.29%. Its 52-week range spans $9.13 to $28.67. Analyst consensus is buy with an average price target of $24.75. Rallies surfaces CC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for CC, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $17.60 |
| Market Cap | $2.76B |
| P/E Ratio | 30.17 |
| EPS | $0.58 |
| Dividend Yield | 0.09% |
| 52-Week High | $28.67 |
| 52-Week Low | $9.13 |
| Volume | 1.75M |
| Avg Volume | 0 |
| Revenue (TTM) | $5.78B |
| Net Income | $86.00M |
| Gross Margin | 19.91% |
9 analysts cover CC: 0 strong buy, 6 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $24.75.